Skip to main content

Shopping Cart

You're getting the VIP treatment!

Item(s) unavailable for purchase
Please review your cart. You can remove the unavailable item(s) now or we'll automatically remove it at Checkout.
itemsitem
itemsitem

Recommended For You

Loading...


tamas bartfai

Showing 1 - 12 of 12 results for “tamas bartfai
Skip side bar filters
  • The Future of Drug Discovery

    Who Decides Which Diseases to Treat?

    The Future of Drug Discovery: Who decides which diseases to treat? provides a timely and detailed look at the efforts of the pharmaceutical industry and how they relate, or should relate, to societal needs. The authors posit that as a result of increasing risk aversion and accelerated savings in research and development, the industry is not developing drugs for increasingly prevalent diseases, ... Read more

    $40.49 USD

  • Drug Discovery

    From Bedside to Wall Street

    Everyone expects something from the drug industry. Physicians and patients, investors, regulators and administrators all have an active interest. Everyone wants to know what makes drugs 'work' medically and economically. Why are drugs so expensive? Is it the drug companies or investors who demand high profits? What governs the pharmacoeconomics? Why are so few diseases treatable? Drug Discovery ... Read more

    $43.19 USD

People who read these also enjoyed

  • Bad Pharma

    How Drug Companies Mislead Doctors and Harm Patients

    by Ben Goldacre ...
    We like to imagine that medicine is based on evidence and the results of fair testing and clinical trials. In reality, those tests and trials are often profoundly flawed. We like to imagine that doctors who write prescriptions for everything from antidepressants to cancer drugs to heart medication are familiar with the research literature about a drug, when in reality much of the research is ... Read more

    $14.39 USD

  • Blue Dreams

    The Science and the Story of the Drugs that Changed Our Minds

    by Lauren Slater ...
    The explosive story of the discovery and development of psychiatric medications, as well as the science and the people behind their invention, told by a riveting writer and psychologist who shares her own experience with the highs and lows of psychiatric drugs.Although one in five Americans now takes at least one psychotropic drug, the fact remains that nearly seventy years after doctors first ... Read more

    $11.99 USD

  • Miracle Medicines

    Seven Lifesaving Drugs and the People Who Created Them

    It’s the business of saving lives.Miracle Medicines goes behind the scenes of the pharmaceutical industry and into the high-security laboratories to tell the stories of the men and women---chemists, physiologists, medical and clinical researchers, engineers---who have chosen to toil for years in the lab in order to transform scientific theories into new lifesaving medicines.You’ll witness the day ... Read more

    $6.99 USD

  • Devalued and Distrusted

    Can the Pharmaceutical Industry Restore its Broken Image?

    An expert's view on solving the challenges confronting today's pharmaceutical industryAuthor John LaMattina, a thirty-year veteran of the pharmaceutical industry and former president of Pfizer's Global R&D Division, is internationally recognized as an expert on the pharmaceutical industry. His first book, Drug Truths: Dispelling the Myths About Pharma R&D, was critically acclaimed for clearing up ... Read more

    $22.00 USD

  • Drug-Like Properties

    Concepts, Structure Design and Methods from ADME to Toxicity Optimization

    Of the thousands of novel compounds that a drug discovery project team invents and that bind to the therapeutic target, only a fraction have sufficient ADME (absorption, distribution, metabolism, elimination) properties, and acceptable toxicology properties, to become a drug product that will successfully complete human Phase I clinical trials. Drug-Like Properties: Concepts, Structure Design and ... Read more

    $179.99 USD

  • Reputation and Power

    Organizational Image and Pharmaceutical Regulation at the FDA

    Series series Princeton Studies in American Politics
    How the FDA became the world's most powerful regulatory agencyThe U.S. Food and Drug Administration is the most powerful regulatory agency in the world. How did the FDA become so influential? And how exactly does it wield its extraordinary power? Reputation and Power traces the history of FDA regulation of pharmaceuticals, revealing how the agency's organizational reputation has been the primary ... Read more

    $45.39 USD

  • Evidence-Based Validation of Herbal Medicine

    Edited by Pulok K. Mukherjee ...
    Evidence-Based Validation of Herbal Medicines brings together current thinking and practice in the areas of characterization and validation of natural products. This book reviews all aspects of evaluation and development of medicines from plant sources, including their cultivation, collection, phytochemical and phyto-pharmacological evaluation, and therapeutic potential. Emphasis is placed on ... Read more

    $202.49 USD

  • Laboratory Animal Anaesthesia

    Laboratory Animal Anesthesia looks at recent significant developments in anesthetic practices in laboratory experiments involving animals. It also provides information about basic standards for proper use of anesthesia. In addition, it examines the equipment and different anesthetic agents that are used in performing an experiment on animals. The book also discusses the profound effects of ... Read more

    $127.79 USD

  • Nanotechnology-Based Approaches for Targeting and Delivery of Drugs and Genes

    Nanotechnology-Based Approaches for Targeting and Delivery of Drugs and Genes provides an overview of the important aspects of nanomedicine in order to illustrate how to design and develop novel and effective drug delivery systems using nanotechnology. The book is organized into three sections, beginning with an introduction to nanomedicine and its associated issues. Section two discusses the ... Read more

    $112.49 USD

  • Monoclonal Antibodies

    Meeting the Challenges in Manufacturing, Formulation, Delivery and Stability of Final Drug Product

    by Steven Shire ...
    Monoclonal antibodies (MAbs) are currently the major class of protein bio therapeutic being developed by biotechnology and pharmaceutical companies. Monoclonal Antibodies discusses the challenges and issues revolving around development of a monoclonal antibody produced by recombinant DNA technology into a therapeutic agent.This book covers downstream processing which includes design of processes ... Read more

    $188.99 USD